BJDX.US Bluejay Diagnostics Inc

Healthcare Health Care Equipment & Supplies USA Stocks
2.61 USD
Close of Nov 14, 2026
1.84 24.84
Market cap
USD 2.92M
P/E
-
P/B
0.31x
ROE
-112.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BJDX.US undervalued?

Graham number

The Graham number of Bluejay Diagnostics Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bluejay Diagnostics Inc fundamental analysis

No fundamental analysis for Bluejay Diagnostics Inc yet.

Bluejay Diagnostics Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bluejay Diagnostics Inc

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops S…

Full company profile